Beam Therapeutics

+$5.78 (+8.74%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BEAM and other stocks, options, and ETFs commission-free!

About BEAM

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing.

CEO

John Evans

Employees

181

Headquarters

Cambridge, Massachusetts

Founded

2017

BEAM Key Statistics

Market Cap

4.50B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.10M

High Today

$72.86

Low Today

$66.01

Open Price

$66.79

Volume

804.40K

52 Week High

$126.90

52 Week Low

$18.76

Analyst Ratings

50%

of 8 ratings

Buy

50%

Hold

50%

Sell

BEAM Earnings

-$3.35

-$2.23

-$1.12

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

-$0.74 per share

Actual

-$3.35 per share